At a cumulative annual growth rate (CAGR) of 6.8%, the global attenuated vaccines market is predicted to rise from US$ 4.45 billion in 2022 to US$ 9.31 billion by 2032. Attenuated vaccination helps in preventing ailments like yellow fever, tuberculosis, measles, retroviral, and likewise. Moreover, it has been reported that there is a re-emergence of …